Skip to main content

Vemurafenib User Reviews & Ratings

Brand names: Zelboraf

Vemurafenib has an average rating of 6.3 out of 10 from a total of 4 reviews on Drugs.com. 50% of reviewers reported a positive experience, while 25% reported a negative experience.

Condition Avg. Rating Reviews Compare
Melanoma, Metastatic  
6.3
 4 reviews for Melanoma, Metastatic 14 medications
Add your review
  • guy56jt
  • April 22, 2012

Zelboraf (vemurafenib) for Melanoma, Metastatic "Cancer returned (metastasized) in abdomen Sept 2011. I ended up in hospital, first parenthesis withdrew 10 liters of abdominal fluid. Given 5 months maximum to live. It is now April 2012. Zelboraf has extended and saved my life. I've been told by specialist in Denver (university of Colorado hospital) that in Europe 42 month life extension has been documented at present time. By dosing with 2 x 240mg pills twice a day! I'd be dead if not for Zelboraf! "

9 / 10
Was this helpful?YesNo
53 Report
  • frm
  • October 31, 2013

Zelboraf (vemurafenib) for Melanoma, Metastatic "Had Isolated Limb Profusion (Left leg) at MD Anderson Cancer center in Houston in Nov 07. Three cancer tumors returned in the same lower left leg in May 2011. In Aug 2011, started Zelboraf at 4 x 240mg pills twice a day (1960mg total a day). Two tumors disappeared within a month of taking Zelboraf. One resisted for six weeks total and was gone. CT and MRI's could find anything after scanning. In July 2013, the one that resisted, returned along with a 5mm nodule. Had some of the complications I was warned about but nothing serious, just uncomfortable at times. Seems like now the cancer is not responding to the Zelboraf and now looking for alternatives. It gave me more years to live with my daughters. Zelboraf is GREAT."

10 / 10
Was this helpful?YesNo
7 Report
  • lilbe...
  • Taken for 1 to 6 months
  • May 26, 2017

Zelboraf (vemurafenib) for Melanoma, Metastatic "I don't have melanoma but was approved for the trial 2B of Zelboraf due to my BRAF mutation ( I have Pancreatic Adenocarcinoma, unresectable, BRAF mutation ) Scans showed a depreciation in size but I couldn't stay on the study or drug due to the effects. I was severely nauseous, had and still do haave horrible ugly painful and itchy raised skin lesions that I am still getting after 3 months off of the drug. I was incapacitated and in bed. Titrated down twice didn't change anything. I was immobilized, felt a severe malaise, could barely get out of bed and months later I am still recovering from the effects of taking the drug. I was pulled from the study by my oncologist due to the toxicity. This was very disappointing as it affected me as badly as Folfironox; its chemo in a pill. Too bad, really."

4 / 10
Was this helpful?YesNo
3 Report
  • suzzett
  • Taken for 1 to 6 months
  • August 16, 2015

Zelboraf (vemurafenib) for Melanoma, Metastatic "Contracted Stevens Johnson's spent 2 months in hospital kidneys shut down 80% of body blistered still having problems 2 years later"

2 / 10
Was this helpful?YesNo
3 Report

Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.